Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,166 papers from all fields of science
Search
Sign In
Create Free Account
C3 Glomerulonephritis
Known as:
Complement-Mediated Membranoproliferative Glomerulonephritis
Glomerulonephritis characterized by C3 accumulation with little or absent deposition of immunoglobulin, in the absence of ultrastructural electron…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Glomerulonephritis
Kidney
Urinary system
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Renal and Pulmonary Dense Deposit Disease Presenting as Pulmonary-Renal Syndrome
R. Nada
,
Ashwani Kumar
,
P. Agrawal
,
R. Ramachandran
,
S. Sethi
Kidney International Reports
2018
Corpus ID: 44084953
2018
2018
Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome…
M. Ciocchini
,
C. Musso
International Urology and Nephrology
2018
Corpus ID: 44085251
2018
2018
A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
Fan Zhang
,
Erzhi Gao
,
S. Liang
,
Nannan Yang
,
Jinquan Wang
Annals of Clinical and Laboratory Science
2018
Corpus ID: 52080015
Monoclonal immunoglobulins have been implicated in the development of C3 glomerulonephritis (C3GN) and Proliferative…
Expand
2017
2017
C3 glomerulonephritis with a severe crescentic phenotype
A. Ravindran
,
F. Fervenza
,
Richard J. H. Smith
,
S. Sethi
Pediatric nephrology (Berlin, West)
2017
Corpus ID: 11645350
BackgroundC3 glomerulopathy (C3G) is rare type of glomerulonephritis resulting from the glomerular deposition of C3 due to…
Expand
Review
2017
Review
2017
Mini review: A unique case of crescentic C3 glomerulonephritis
D. Palamuthusingam
,
M. Mantha
,
K. Oliver
,
K. Bavishi
,
Shyam Dheda
Nephrology
2017
Corpus ID: 12573724
Kidney involvement is an under‐recognized complication of non‐Hodgkin lymphomas. They occur in a variety of mechanisms and differ…
Expand
2016
2016
De novo C3 glomerulonephritis in a renal allograft
J. Nahm
,
S. Song
,
+4 authors
H. Jeong
Ultrastructural Pathology
2016
Corpus ID: 207442654
ABSTRACT C3 glomerulonephritis (C3GN) is a recently described, rare glomerular disease characterized by predominant or sole…
Expand
2016
2016
Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
Arshad Ali
,
L. Schlanger
,
S. Nasr
,
S. Sethi
,
S. Gorbatkin
American Journal of Kidney Diseases
2016
Corpus ID: 7451278
Dense deposit disease (DDD) is a rare form of glomerulonephritis that has recently been reclassified under the broad group of C3…
Expand
2014
2014
Generation of Multiple Fluid-Phase C3b:Plasma Protein Complexes during Complement Activation: Possible Implications in C3 Glomerulopathies
Mahalakshmi Ramadass
,
B. Ghebrehiwet
,
Richard J. H. Smith
,
R. Kew
Journal of Immunology
2014
Corpus ID: 7029489
The complement system is tightly regulated to safeguard against tissue damage that results from unwanted activation. The key step…
Expand
2013
2013
C 3 glomerulonephritis and CFHR 5 nephropathy
Jens Jordan
,
S. Linnenweber-Held
,
Hermann Haller
2013
Corpus ID: 11278022
Complement is an important aspect of defence against infection and its activation and regulation are finely balanced. Disordered…
Expand
2012
2012
C3 glomerulonephritis associated with a missense mutation in the factor H gene.
K. Sugimoto
,
S. Fujita
,
Kouhei Miyazaki
,
M. Okada
,
T. Takemura
Tohoku journal of experimental medicine
2012
Corpus ID: 8171192
The complement system, the major component of the innate immune functions resisting microbial infection, includes the classical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE